RespireRX Pharmaceuticals Inc.

Investors

Investor Highlights

Ticker Symbol: CORX.OB
Fiscal Year End: December 31

In the News

Cortex Pharmaceuticals, Inc. to Present at the 14th Annual BIO Investor Forum

10/20/15 – Cortex Slide Deck presentation at the 14th Annual BIO Investor Forum

Cortex Pharmaceuticals, Inc. to Present at Rodman & Renshaw 17th Annual Global Investment Conference

9/10/15 – Cortex Slide Deck presentation at Rodman and Renshaw 17th Annual Global Investment Conference

Cortex Slide Deck - May 15, 2015 (updated slide deck of May 4, 2015 presented at NYBIO Conference)>>>

5/4/15 – Cortex Pharmaceuticals, Inc. Announces Publication of Research Results on the Use of Ampakines CX1739 and CX717 in the Treatment of Respiratory Disorders >>>

Cortex Pharmaceuticals, Inc. to Present at NewYorkBIO 25th Anniversary Conference >>>

NYBIO Conference Presentation >>>

4/6/15 – Cortex Pharmaceuticals, Inc. Files December 31, 2014 Annual Report on Form 10-K; Provides Update on Current Status and Activities >>>

1/9/15 – Cortex Pharmaceuticals, Inc. to Present at 7th Annual Biotech Showcase™ 2015 >>>

Access Webcast >>>

View Interview with Dr. Arnold Lippa >>>

12/2/2014 – Cortex Pharmaceuticals, Inc. to Participate in 7th Annual Biotech Showcase 2015™ being held in San Francisco, California from January 12 – 15, 2015 >>>

9/24/14 – Cortex Pharmaceuticals, Inc. Announces Phase 1 Funding by the National Institute of Drug Abuse, National Institutes of Health, under the Small Business Innovation Research Funding Award Program Cortex Pharmaceuticals, Inc. Also Announces Appointment of Chairman of Scientific Advisory Board >>>

9/4/14 – Cortex Pharmaceuticals, Inc. Announces Appointment of Two Directors; Expands Board to Five Members >>>